Researchers targeting colorectal cancer stem cells – the root cause of disease, resistance to treatment and relapse – have discovered a mechanism to mimic a virus and potentially trigger an immune response to fight the cancer like an infection.
New research from Toronto Western Hospital’s Spodyloarthritis Program reveals people with a type of spinal arthritis called ankylosing spondylitis (AS) have a higher risk of dying from a heart attack or stroke than the general population.
TestYourLimits initiative takes on the Nahanni River in Canada’s North to raise awareness about heart disease and organ donation.
A deceased donor liver has been preserved and kept healthy outside the body in a device that mimics the body’s physiological functions and successfully transplanted into a human, for the first time in Ontario.
The Much Music Video Awards (MMVA) boast their celebrity quotient. So does the Toronto International Film Festival (TIFF). But hockey has its own parade of celebrities, as Road Hockey To Conquer Cancer stages its fifth annual event, and along with 2,000 participants, will host more than 50 celebrities.
New chair to spearhead development of novel approaches to treat patients with inherited or acquired cardiac disease
Using a proactive approach to encourage optimal heart health through a blend of leading medical knowledge and best practices in fitness and exercise, the Peter Munk Cardiac Centre today unveiled a new website featuring medical information, step-by-step instruction and individual exercise videos as part of a proven effective fitness program.
A landmark clinical study in the Lancet provides convincing evidence that a frequently overlooked therapy for genetically-caused emphysema is effective and slows the progression of lung disease.
Philanthropist and cardiac patient Heather Cartwright and family enable novel research with generous gift.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
The Princess Margaret Cancer Foundation announces the launch of a new marketing campaign called ‘Why is in our DNA.’ The campaign is the next creative evolution in our Billion Dollar Challenge in support of Personalized Cancer Medicine at the Princess Margaret Cancer Centre.
The University Health Network, one of Canada’s largest teaching and research hospital networks, and The Michener Institute for Applied Health Sciences, the only education institution in Canada devoted exclusively to applied health sciences education, have announced their intent to explore a unique partnership aimed at creating a first-of-its-kind health learning organization in Canada.
Members of University Health Network’s Multi-Organ Transplant (MOT) Team will be available to the media and will provide an update on Eugene Melnyk’s transplant, living liver transplantation and the process used for anonymous donation.
The use of personalized music playlists with tempo-pace synchronization increases adherence to cardiac rehab by almost 70 per cent—according to a study published in Sports Medicine –Open.
Road Hockey to Conquer Cancer, the dawn-to-dusk fundraising event benefiting the Princess Margaret Cancer Centre, is pleased to announce that SHOP.CA (www.shop.ca) has signed on as the Official Presenting Sponsor of Road Hockey to Conquer Cancer 2015.
The results of three brain autopsies announced this week by the Krembil Neuroscience Centre’s Canadian Sports Concussion Project (CSCP) show the varying outcomes that can result in brains of former athletes who sustained multiple concussions.
Women with luminal A subtype breast cancer – and particularly those older than 60 – may not need radiation treatment if they are already taking hormone therapy, shows clinical research led by radiation oncologists at the Princess Margaret Cancer Centre published online today in the Journal of Clinical Oncology.
The Toronto General Hospital today becomes the first healthcare institution in the world to unveil a novel technology-based platform aimed at shortening the time required to translate medical research into clinical practice. This will enable faster diagnoses and more rapid treatment for patients with heart disease and other conditions that are detected using advanced medical imaging devices.
A commonly-used drug to treat inflammatory bowel disease, such as Crohn’s disease, has been shown to lower blood sugar levels in obese mice, potentially identifying the gut immune system as a new and effective target in treating diabetes in humans.
Researchers at the Toronto General Hospital Research Institute have discovered metformin (the most widely prescribed type 2 diabetic medication) and resveratrol, a compound found in red wine, trigger novel signaling pathways in the small intestine to lower blood sugar.
Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially deliver targeted, therapeutic payloads.
Paper in The Lancet Diabetes and Endocrinology shows glucose-lowering therapies pose increased cardiac risk
University Health Network (UHN) has launched a new online resource designed to profile the organization’s experts who work frequently with media.
A new, large-scale Canadian study shows that many adults with traumatic brain injury (TBI) live in a long-term health setting – such as a nursing home- which may not be appropriate for their condition and younger age.
Two internationally acclaimed cancer centres today announced a partnership to accelerate academic and clinical research to advance personalized, targeted therapies against cancer.
A new, first-of-its-kind app has launched to help patients suffering from chronic pain track their opioid use and measure pain levels to assist with the safe use of opioids.
Researchers at the Princess Margaret Cancer Centre are proposing a new model to enable doctors to predict outcomes more accurately for patients with throat cancers specifically caused by Human Papillomavirus (HPV).
An equal group of leading healthcare professionals, patients and caregivers meet to define priorities for Kidney Cancer research and treatment.
The Princess Margaret Cancer Centre, one of the top 5 cancer research centres in the world, received a substantial boost today from TD Bank Group. A $1-million gift will establish the TD Collaboration and Recruitment Fund to recruit post-doctoral students, fellows and other researchers to The Princess Margaret. Recruitment is an integral part of The Princess Margaret’s Billion Dollar Challenge for Personalized Cancer Medicine.
A unique new method to treat a specific group of patients who are at greater risk of rejecting a donor lung, allowing them to live longer after transplant without rejection, has been developed by the Toronto Lung Transplant Program at Toronto General Hospital, University Health Network.
The Princess Margaret Cancer Foundation’s world-leading Road Hockey to Conquer Cancer event is very excited to announce a partnership with VIA Rail Canada that will help expedite the growth of the Toronto-based fundraising event in 2015.
The amount of time a person sits during the day is associated with a higher risk of heart disease, diabetes, cancer, and death, regardless of regular exercise— according to a review study published today in the Annals of Internal Medicine.
JDRF and the Centre for Global eHealth Innovation at the University Health Network (UHN) in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network (JDRF CCTN) funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
Peter Munk Cardiac Centre unveils platform that targets youth transitioning to adult medical setting
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.
A world-first pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network. Further details will be provided at a media availability session.
The Jesse and Julie Rasch Foundation of Toronto has provided a generous gift of $130,000 to identify agents that specifically target the Hodgkin’s Lymphoma microenvironment.
A surgical team at the Peter Munk Cardiac Centre led by internationally-acclaimed cardiovascular surgeon, Dr. Vivek Rao, has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced heart failure.
The teams at GoodLife Fitness and the Peter Munk Cardiac Centre (PMCC) have been hard at work over the last two years building a solid foundation for their unique, first-of-its-kind public/private collaboration to advance cardiac care and preventative programs.
Researchers at the Krembil Neuroscience Centre have potentially discovered a major cause of dementia. In this type of dementia, there is damage to the white matter (nerve fibres) of the brain apparent on computerized tomography (CT) and magnetic resonance imaging (MRI) scans of older individuals.
Dr. Robert Devenyi and Dr. Samuel Markowitz will give a presentation followed by a Q and A session on the successful implantation of Canada’s first eye prosthesis system, a device that restores functional vision in patients with forms of advanced retinitis pigmentosa.
Dr. Robert Devenyi and Dr. Samuel Markowitz will give a presentation followed by a Q and A session on the successful implantation of Canada’s first eye prosthesis system, a device that restores functional vision in patients with forms of advanced retinitis pigmentosa, on Tuesday, October 14 at 11 a.m. (ET).
Leading Canadian spinal cord injury (SCI) experts have launched the unprecedented Spinal Cord Injury: A Manifesto for Change—a call to action and a plea for Canadian health-care providers and stakeholders to work in coordination to improve care and the health of people living with SCI in Canada.
Inaugural event to educate healthcare providers on diabetes treatment as rates soar.
The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Centre, York University and UHN.
Thanks to a generous gift of $2.4 million from Elizabeth and Tony Comper, the Princess Margaret Cancer Centre will establish the Myeloproliferative Neoplasm Program (MPN); the first of its kind in Canada.
Mr. John Mulvihill, Chair of the Board of Trustees of University Health Network (UHN) and Chair of the Board's Selection Committee for the President & CEO announced today that Dr. Peter Pisters, currently Vice President of The University of Texas MD Anderson Cancer Center’s Regional Care System, will serve as UHN’s next President & CEO.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right